Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Biological characterization of compounds from Rhinella schneideri poison that act on the complement system (2015)

  • Authors:
  • USP affiliated authors: BRAGA, ELIANE CANDIANI ARANTES - FCFRP ; BORDON, KARLA DE CASTRO FIGUEIREDO - FCFRP ; AZZOLINI, ANA ELISA CALEIRO SEIXAS - FCFRP ; CROTT, LUCIANA SIMON PEREIRA - FCFRP
  • USP Schools: FCFRP; FCFRP; FCFRP; FCFRP
  • DOI: 10.1186/s40409-015-0024-9
  • Subjects: VENENOS DE ORIGEM ANIMAL; BUFONIDAE; TOXINAS (ISOLAMENTO E PURIFICAÇÃO)
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1186/s40409-015-0024-9 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: bronze
    • Licença: cc-by
    Versões disponíveis em Acesso Aberto do: 10.1186/s40409-015-0024-9 (Fonte: Unpaywall API)

    Título do periódico: Journal of Venomous Animals and Toxins including Tropical Diseases

    ISSN: 1678-9199

    • Melhor URL em Acesso Aberto:
      • Página do artigo
      • Evidência: open (via page says license)
      • Licença: cc-by
      • Versão: publishedVersion
      • Tipo de hospedagem: publisher


    • Outras alternativas de URLs em Acesso Aberto:
        • Página do artigo
        • Evidência: open (via page says license)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: publisher


        • Página do artigo
        • Evidência: oa journal (via doaj)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: publisher




        • Página do artigo
        • Link para o PDF
        • Evidência: oa repository (via OAI-PMH title and first author match)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


        • Página do artigo
        • Evidência: oa repository (via pmcid lookup)
        • Licença:
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


    Informações sobre o Citescore
  • Título: Journal of Venomous Animals and Toxins Including Tropical Diseases

    ISSN: 1678-9199

    Citescore - 2017: 1.95

    SJR - 2017: 0.573

    SNIP - 2017: 0.952


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FCFRP2720232pcd 2720232 Estantes Deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ANJOLETTE, Fernando A. P.; LEITE, Flávia P.; BORDON, Karla de Castro Figueiredo; et al. Biological characterization of compounds from Rhinella schneideri poison that act on the complement system. Journal of Venomous Animals and Toxins Including Tropical Diseases, London, v. 21, 2015. Disponível em: < http://dx.doi.org/10.1186/s40409-015-0024-9 > DOI: 10.1186/s40409-015-0024-9.
    • APA

      Anjolette, F. A. P., Leite, F. P., Bordon, K. de C. F., Azzolini, A. E. C. S., Pereira, J. C., Crott, L. S. P., & Arantes, E. C. (2015). Biological characterization of compounds from Rhinella schneideri poison that act on the complement system. Journal of Venomous Animals and Toxins Including Tropical Diseases, 21. doi:10.1186/s40409-015-0024-9
    • NLM

      Anjolette FAP, Leite FP, Bordon K de CF, Azzolini AECS, Pereira JC, Crott LSP, Arantes EC. Biological characterization of compounds from Rhinella schneideri poison that act on the complement system [Internet]. Journal of Venomous Animals and Toxins Including Tropical Diseases. 2015 ; 21Available from: http://dx.doi.org/10.1186/s40409-015-0024-9
    • Vancouver

      Anjolette FAP, Leite FP, Bordon K de CF, Azzolini AECS, Pereira JC, Crott LSP, Arantes EC. Biological characterization of compounds from Rhinella schneideri poison that act on the complement system [Internet]. Journal of Venomous Animals and Toxins Including Tropical Diseases. 2015 ; 21Available from: http://dx.doi.org/10.1186/s40409-015-0024-9

    Referências citadas na obra
    AmphibiaWeb. Information on amphibian biology and conservation. Species Numbers, 2000. http://www.amphibiaweb.org/amphibian/speciesnums.html . Accessed 13 Nov 2014.
    Frost D. Amphibian species of the world 6.0, an online reference. http://research.amnh.org/herpetology/amphibia/index.html . Accessed 10 Nov 2014.
    Maciel NM, Collevatti RG, Colli GR, Schwartz EF. Late Miocene diversification and phylogenetic relationships of the huge toads in the Rhinella marina (Linnaeus, 1758) species group (Anura: Bufonidae). Mol Phylogenet Evol. 2010;57(2):787–97.
    Clarke BT. The natural history of amphibian skin secretions, their normal functioning and potential medical applications. Biol Rev Camb Philos Soc. 1997;72(3):365–79.
    Sakate M. Lucas de Oliveira PC. Toad envenoming in dogs: effects and treatment. J Venom Anim Toxins. 2000;6(1):52–62.
    Toledo RC, Jared C. Cutaneous granular glands and amphibian venoms. Comp Biochem Phys A. 1995;111(1):1–29.
    Lee S, Lee Y, Choi YJ, Han KS, Chung HW. Cyto-/genotoxic effects of the ethanol extract of Chan Su, a traditional chinese medicine, in human cancer cell lines. J Ethnopharmacol. 2014;152(2):372–6.
    Chow L, Johnson M, Wells A, Dasgupta A. Effect of the traditional Chinese medicines Chan Su, Lu-Shen-Wan, Dan Shen, and Asian ginseng on serum digoxin measurement by Tina-quant (Roche) and Synchron LX system (Beckman) digoxin immunoassays. J Clin Lab Anal. 2003;17(1):22–7.
    Chen KK, Koraríková A. Pharmacology and toxicology of toad venom. J Pharm Sci. 1967;56(12):1535–41.
    Gomes A, Giri B, Alam A, Mukherjee S, Bhattacharjee P, Gomes A. Anticancer activity of a low immunogenic protein toxin (BMP1) from Indian toad (Bufo melanostictus, Schneider) skin extract. Toxicon. 2011;58(1):85–92.
    Zhang L, Nakaya K, Yoshida T, Kuroiwa Y. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res. 1992;52(17):4634–41.
    Zuo-Qing L. Traditional Chinese medicine for primary liver cancer. World J Gastroenterol. 1998;4(4):360–4.
    Yeh JY, Huang WJ, Kan SF, Wang PS. Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate. 2003;54(2):112–24.
    Shen S, Zhang Y, Wang Z, Liu R, Gong X. Bufalin induces the interplay between apoptosis and autophagy in glioma cells through endoplasmic reticulum stress. Int J Biol Sci. 2014;10(2):212–24.
    Jiang L, Zhao MN, Liu TY, Wu XS, Weng H, Ding Q, et al. Bufalin induces cell cycle arrest and apoptosis in gallbladder carcinoma cells. Tumour Biol. 2014;35(11):10931–41.
    Assis AI, Barbosa JE, Carvalho IF. Anticomplementary fraction from the poisonous secretion of paratoid gland of the toad (Bufo marinus paracnemis Lutz). Experientia. 1985;41(7):940–2.
    Janeway CA, Travers P, Walport M, Shlomchik MJ. O sistema complemento e a imunidade inata. In: Janeway Junior CA, Shlomchik MJ, Travers P, Walport M, editors. Imunobiologia: o sistema imune na saúde e na doença. 5th ed. Porto Alegre: Artmed; 2002. p. 63–83.
    Sarma JV, Ward PA. The complement system. Cell Tissue Res. 2011;343(1):227–35.
    Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785–97.
    Arantes EC, Prado WA, Sampaio SV, Giglio JR. A simplified procedure for the fractionation of Tityus serrulatus venom: isolation and partial characterization of TsTX-IV, a new neurotoxin. Toxicon. 1989;27(8):907–16.
    Laemmli UK. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680–5.
    Harrison RA, Lachmann PJ. Complement technology. In: Weir DM, editor. Handbook of experimental immunology. Oxford, UK: Blackwell Scientific Publications; 1986. p. 39.1–39.49.
    Hoffmann LG, Mayer MM. Immune hemolysis and complement fixation. In: Williams CA, Chase MW, editors. Methods in immunology and immunochemistry. New York: Academic; 1977. p. 140.
    Paula FS, Kabeya LM, Kanashiro A, de Figueiredo AS, Azzolini AE, Uyemura AS, et al. Modulation of human neutrophil oxidative metabolism and degranulation by extract of Tamarindus indica L. fruit pulp. Food Chem Toxicol. 2009;47(1):163–70.
    Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med. 1962;115:453–66.
    Zigmond SH, Hirsch JG. Leukocyte locomotion and chemotaxis: new methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973;137(2):387–410.
    Clarke HG, Freeman T. Quantitative immunoelectrophoresis of human serum proteins. Clin Sci. 1968;35(2):403–13.
    Deppisch R, Schmitt V, Bommer J, Hänsch GM, Ritz E, Rauterberg EW. Fluid phase generation of terminal complement complex as a novel index of bioincompatibility. Kidney Int. 1990;37(2):696–706.
    Marongio AFQ. Isolamento e caracterização parcial do componente do veneno de Bufo paracnemis com ação sobre o sistema complemento. Estudos in vitro e atividade proteolítica. MSs Thesis. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto – USP; 2006.
    Bertazzi DT, de Assis-Pandochi AI, Talhaferro VL. Caleiro Seixas Azzolini AE, Pereira Crott LS, Arantes EC. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom. Int Immunopharmacol. 2005;5(6):1077–84.
    Bertazzi DT, de Assis-Pandochi AI, Azzolini AE, Talhaferro VL, Lazzarini M, Arantes EC. Effect of Tityus serrulatus scorpion venom and its major toxin, TsTX-I, on the complement system in vivo. Toxicon. 2003;41(4):501–8.
    Farsky SH, Gonçalves LR, Gutíerrez JM, Correa AP, Rucavado A, Gasque P, et al. Bothrops asper snake venom and its metalloproteinase BaP-1 activate the complement system. Role in leucocyte recruitment. Mediators Inflamm. 2000;9(5):213–21.
    Silva WDD, Tambourgi DV, Campos ACMR, Magnoli F, Petricevich VL, Kipnis TL. Complement activation by animal venoms. Toxin Rev. 1995;14(3):375–400.
    Gebel HM, Finke JH, Elgert KD, Campbell BJ, Barret JT. Inactivation of complement by Loxosceles reclusa spider venom. Am J Trop Med Hyg. 1979;28(4):756–62.
    Tanaka GD, Pidde-Queiroz G, Furtado MFD, van den Berg C, Tambourgi DV. Micrurus snake venoms activate human complement system and generate anaphylatoxins. BMC Immunol. 2012;13:4.
    Lai R, Zhao Y, Yang D-M, Zha H, Lee W, Zhang Y. Comparative study of the biological activities of the skin secretions from six common Chinese amphibians. Zool Res. 2000;23(2):113–9.
    Farsky SH, Walber J, Costa-Cruz M, Cury Y, Teixeira CF. Leukocyte response induced by Bothrops jararaca crude venom: in vivo and in vitro studies. Toxicon. 1997;35(2):185–93.
    Tambourgi DV, Dos Santos MC, Furtado MFD, de Freitas MCW, da Silva WD, Kipnis TL. Pro-inflammatory activities in elapid snake venoms. Br J Pharmacol. 1994;112(3):723–7.
    Chen T, Shaw C. Identification and molecular cloning of novel trypsin inhibitor analogs from the dermal venom of the Oriental fire-bellied toad (Bombina orientalis) and the European yellow-bellied toad (Bombina variegata). Peptides. 2003;24(6):873–80.
    Conlon JM, Kim JB. A protease inhibitor of the Kunitz family from skin secretions of the tomato frog, Dyscophus guineti (Microhylidae). Biochem Biophys Res Commun. 2000;279(3):961–4.
    Mignogna G, Pascarella S, Wechselberger C, Hinterleitner C, Mollay C, Amiconi G, et al. BSTI, a trypsin inhibitor from skin secretions of Bombina bombina related to protease inhibitors of nematodes. Protein Sci. 1996;5(2):357–62.
    Chakrabarty AK, Saha K, Sen P, Sharma KK, Agarwal SK. Effects of antibacterial agents on the complement system. Immunopharmacology. 1981;3(4):281–7.
    Roos A, Nauta AJ, Broers D, Faber-Krol MC, Trouw LA, Drijfhout JW, et al. Specific inhibition of the classical complement pathway by C1q-binding peptides. J Immunol. 2001;167(12):7052–9.
    Furlong S, Dutta A, Coath M, Gormley J, Hubbs S, Lloyd D, et al. C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl alpha-ketoheterocycles. Immunopharmacology. 2000;48(2):199–212.
    Soulika AM, Holland MC, Sfyroera G, Sahu A, Lambris JD. Compstatin inhibits complement activation by binding to the beta-chain of complement factor 3. Mol Immunol. 2006;43(12):2023–9.
    Gutiérrez JM, Romero M, Diaz C, Borkow G, Ovadia M. Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo). Toxicon. 1995;33(1):19–29.
    Rus V, Malide D, Bolosiu HD, Parasca I, Dutu AL. Levels of SC5b--9 complement complex in plasma and synovial fluid of patients with rheumatic disease. Med Interne. 1990;28(4):305–10.
    Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol. 2004;138(3):439–46.
    Harboe M, Garred P, Karlstrom E, Lindstad JK, Stahl GL, Mollnes TE. The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification. Mol Immunol. 2009;47(2–3):373–80.
    Vogel CW, Finnegan PW, Fritzinger DC. Humanized cobra venom factor: structure, activity, and therapeutic efficacy in preclinical disease models. Mol Immunol. 2014;61(2):191–203.
    Mao YF, Yu QH, Zheng XF, Liu K, Liang WQ, Wang YW, et al. Pre-treatment with Cobra venom factor alleviates acute lung injury induced by intestinal ischemia-reperfusion in rats. Eur Rev Med Pharmacol Sci. 2013;17(16):2207–17.
    Vogel CW, Fritzinger DC, Gorsuch WB, Stahl GL. Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseases. Thromb Haemost. 2015;113(3):548–52.
    Vogel CW, Fritzinger DC. Cobra venom factor: structure, function, and humanization for therapeutic complement depletion. Toxicon. 2010;56(7):1198–222.
    Vogel CW, Fritzinger DC, Hew BE, Thorne M, Bammert H. Recombinant cobra venom factor. Mol Immunol. 2004;41(2–3):191–9.